Cymbalta approved for Fibromyalgia - The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Li… more →
Impactiviti blogRusty wrote 1 month ago: I see two armies. Both of them are separated by a small sea. I fly around, looking at them at a grea … more →
kingofindy wrote 1 month ago: STYLE-E 19/07/08 ‘Sparking! E Super Warrior’ West Chufu Fighting Arena 1. Masashi Takeda … more →
crimsoncanary wrote 1 month ago: Takeda have submitted a New Drug Application to the Ministry of Health Labour and Welfare in Japan f … more →
crimsoncanary wrote 1 month ago: Data presented today at the 10th World Congress on Gastrointestinal Cancer shows that preemptive tre … more →
Steve Woodruff wrote 1 month ago: Cymbalta approved for Fibromyalgia - The U.S. Food and Drug Administration (FDA) has approved Cymbal … more →
crimsoncanary wrote 2 months ago: Takeda has requested a re-examination of its European application for melatonin agonist ramelteoon. … more →
Steve Woodruff wrote 2 months ago: A ton of cancer news out of ASCO (American Society of Clinical Oncology). We’ll get to those i … more →
crimsoncanary wrote 3 months ago: Chloride channel agonist Amitiza (lubiprostone) had been shown to significantly relieve symptoms of … more →
sakuramochi wrote 3 months ago: Michimasa Takeda is not a delinquent juvenile. But, his look make people want to set a fight with hi … more →
Steve Woodruff wrote 3 months ago: BMS to sell off ConvaTec - Drug developer Bristol-Myers Squibb Co. said Friday it will sell its woul … more →
crimsoncanary wrote 3 months ago: The FDA has approved Amitiza for the addtitional indication of irritable bowel syndrome with constip … more →
Steve Woodruff wrote 4 months ago: We are loaded up this week! Can Enbrel reverse Alzheimers? - Alzheimer’s patients given a drug … more →
danielteper wrote 4 months ago: Takeda is offering almost $ 9 billion for Cambridge, MA based Millenium Pharmaceuticals. This is a 5 … more →
Steve Woodruff wrote 4 months ago: Novartis buying up Alcon - Novartis AG has agreed to buy Nestle AG’s 77 percent stake in U.S. … more →
Steve Woodruff wrote 4 months ago: Breaking news from the ACC: Vytorin/Zetia gets panned - shows no benefit on the primary endpoint, th … more →
Steve Woodruff wrote 5 months ago: Cephalon’s Treanda approved for leukemia: Cephalon Inc. received clearance from regulators yes … more →
Steve Woodruff wrote 5 months ago: The rumor that has swirled around today appears to now be confirmed - Abbott and Takeda are going to … more →
lallypockets wrote 6 months ago: I am awful at posting. I should fix this. In any case, here’s what I have: COMPLETED: -A ros … more →
Steve Woodruff wrote 7 months ago: So, who is getting all those free drug samples, anyway? The poor, or the wealthy insured? A recent s … more →